The following pages contain information relating to a proposed capital increase of AFFLUENT MEDICAL that, if carried out, would only be offered to the public in France.
This website and the information contained herein are not intended for, and should not be viewed by, distributed or disseminated to persons resident of or physically present in the United States of America (including the territories of the United States, hereinafter the "United States"), Canada, Japan or Australia, and do not constitute an offer to sell or subscribe for or a solicitation of an order to purchase or subscribe for shares or securities of AFFLUENT MEDICAL in the United States, Canada, Japan or Australia. The securities of AFFLUENT MEDICAL mentioned on this website have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), and may not be offered or sold in the United States unless exempt from the registration requirements of the Securities Act, and AFFLUENT MEDICAL does not intend to make a public offering of securities in the United States.
Any person residing outside of France and outside of the United States, Canada, Japan and Australia, wishing to access the documents contained on this website must first ensure that he or she is not subject to local laws and regulations prohibiting or restricting his or her right to access this website or requiring any registration or authorisation for the purpose of acquiring financial securities. No such registration or authorisation has been or will be obtained outside France. AFFLUENT MEDICAL shall not be liable for any breach of applicable laws and regulations by any person.
In any member state of the European Economic Area (other than France), and in the United Kingdom, the information contained in this website is solely addressed to persons who are "qualified investors" within the meaning of Regulation (EU) 2017/1129 of June 14, 2017, as amended (the "Prospectus Regulation", which term applies in respect of the United Kingdom as part of United Kingdom domestic law under the European Union Withdrawal Ac 2018). The financial securities referred to are only being offered to qualified investors and any invitation, offer or agreement to subscribe for, purchase or acquire such financial securities will only be made to qualified investors. Any person who is not a qualified investor should not act or rely on this information or its contents.
In addition, in the United Kingdom, the information contained in this website may only be accessed by qualified investors 19(i) who are investment professionals within the meaning of Article 19(5) ("investment professionals") of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order"), or 19(ii) who fall within Article 49(a) to (d) of the Order ("high net worth companies, unregistered associations etc.") (all such persons being hereinafter referred to as "Authorised Persons"). Any person other than an Authorised Person must not use or rely on this website or the information it contains. Any investment or investment activity referred to on this website and in the information contained herein is available only to Authorised Person and will be entered into only with Authorised Person.
I therefore certify that:
(1) I am resident of, and physically present in, France
(2) I am resident of, and physically present in, one of the Member States of the European Economic Area (other than France) or the United Kingdom and I am a qualified investor within the meaning of Regulation (EU) 2017/1129 of June 14, 2017 ("Prospectus Regulation")
(3) I am not resident or physically present in the United States, Canada, Japan or Australia.
I have read and understood this disclaimer and give the above mentioned warranties, and agree to comply with the above mentioned conditions: